Treatment with abatacept led to a reduction in skin stiffening and disability, as well as…
Articles by Steve Bryson, PhD
Rituximab, in combination with CellCept (mycophenolate mofetil), reverses the decline in lung…
A triple combination of prednisolone, cyclophosphamide and plasma exchange (plasmapheresis) was effective against skin thickening in seven…
EHP-101, an oral therapy based on cannabidiol (CBD),…
A statistical model applied to a widely used measure of skin thickening in people newly diagnosed with…
Immune players known as dendritic cells play a key role in scleroderma development in the skin and may…
Localized scleroderma affects health-related quality of life (HRQoL) in young people,…
A large-scale DNA analysis in different tissues revealed an association between scleroderma and groups of genes driving well-known inflammation pathways.
A Phase 2a clinical trial designed to test Galapagos‘ investigational oral therapy GLPG1690 in…
People with diffuse cutaneous scleroderma (dcSSc) being treated with lenabasum…